Anti-Fungal (Aspergillus fumigatus) Activity of Pseudomonas aeruginosa in Cystic Fibrosis Synthetic Sputum
Pathogens · 2024
DOI: 10.3390/pathogens13100875 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von Gabriele Sass und 2 weiteren Autor:innen. Beteiligte Einrichtung: California Institute for Medical Research, San Jose, CA 95128, USA. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Cystic Fibrosis, Aspergillus fumigatus, Sputum. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for Research in Infectious Diseases (FRID).
Abstract (Originalsprache)
Aspergillus fumigatus (Af) and Pseudomonas aeruginosa (Pa) are pathogens inhabiting the lungs of persons with cystic fibrosis (CF), or immune-compromised patients, causing or aggravating disease. We previously investigated their microbial interaction as well as susceptibility to anti-fungal drugs using RPMI medium (contains undetectable iron concentrations), as is standard for susceptibility testing. Here we investigated microbial interaction in synthetic sputum medium (SSPM), a complex mixture designed to mimic the milieu in CF lungs. SSPM contains Fe2+. Pa laboratory strain PA14 or PA14 siderophore mutant planktonic culture filtrate, prepared in RPMI or SSPM, were compared for inhibition of Af biofilm formation. SSPM enhanced bacterial and fungal growth and the production of the Pa molecules pyoverdine, phenazines, and rhamnolipids. Af was more susceptible to these molecules in SSPM (with the exception of pyoverdine). SSPM interfered with fungal susceptibility to pyoverdine. Studies with the mutant helped to reveal that the reduced anti-fungal activity of pyoverdine in SSPM appears to be compensated by higher production of other anti-fungal molecules, e.g., rhamnolipids, phenazines, and PQS, and higher Af sensitivity to these molecules. In summary, SSPM better defines Pa–Af intermicrobial competition in the milieu of CF lungs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- California Institute for Medical Research, San Jose, CA 95128, USA.
- Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
Förderung
- Foundation for Research in Infectious Diseases (FRID)
Zitieren
APA
Sass, G., Kethineni, S., & Stevens, D. A. (2024). Anti-Fungal (Aspergillus fumigatus) Activity of Pseudomonas aeruginosa in Cystic Fibrosis Synthetic Sputum. Pathogens. https://doi.org/10.3390/pathogens13100875
Vancouver
Sass G, Kethineni S, Stevens DA. Anti-Fungal (Aspergillus fumigatus) Activity of Pseudomonas aeruginosa in Cystic Fibrosis Synthetic Sputum. Pathogens. 2024. doi:10.3390/pathogens13100875
BibTeX
@article{Sass2024,
author = {Sass, Gabriele and Kethineni, Satya and Stevens, David A},
title = {Anti-Fungal (Aspergillus fumigatus) Activity of Pseudomonas aeruginosa in Cystic Fibrosis Synthetic Sputum},
journal = {Pathogens},
year = {2024},
doi = {10.3390/pathogens13100875}
}
EUVIMED